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A B S T R A C T
Group C streptococci (GCS) and group G b-haemolytic streptococci (GGS) have caused well-
documented epidemics of acute pharyngitis in children, but the importance of these organisms in
causing endemic or sporadic pharyngitis is uncertain. The heterogeneity of GCS and GGS may obscure
the role of certain subtypes, such as the large-colony-forming strains of group C (Streptococcus
dysgalactiae subsp. equisimilis) or group G, in endemic pharyngitis. For a 1-year period, children (aged
6 months to 18 years) (n ¼ 2085) who presented with pharyngitis to the children’s hospital emergency
department and two outpatient offices were enrolled in a cross-sectional study to ascertain the role of
large-colony-forming GCS and GGS in acute pharyngitis. Control patients (n ¼ 194) were children who
presented to the same locations during the same time period with non-respiratory tract symptoms or to
the orthopaedic cast clinic. Throat cultures were obtained by a standard reference method, and swabs
were plated on Strep-Selective Agar. Lancefield grouping and species identification was performed on
all b-haemolytic isolates. In total, 65 (3%) large-colony-forming GCS and GGS strains were obtained
from pharyngitis patients, and three (1.5%) were obtained from the control group (odds ratio 2.0; 95%
confidence interval 0.6–6.1). The low isolation rate of large-colony-forming strains of GCS and GGS
indicates that even if these organisms are associated with acute, sporadic pharyngitis in paediatric
patients, they represent an unusual pathogen.
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I N T R O D U C T I O N
Non-group A b-haemolytic streptococci, partic-
ularly Lancefield groups C (GCS) and G (GGS),
have been implicated as causes of acute pharyn-
gitis in children [1–7] and adults [8–11]. These
organisms have caused well-documented epi-
demic, often food-borne, outbreaks of pharyngitis
[2–7]. The importance of these organisms in
causing acute, sporadic pharyngitis is uncertain.
In addition to being classified by Lancefield
group carbohydrate, the b-haemolytic strepto-
cocci are distinguished morphologically as being
large-colony or small-colony formers on sheep
blood agar [8,12,13]. The large-colony-forming
phenotypes of group A and group B b-haemolytic
streptococci are the pathogenic species Streptococ-
cus pyogenes and Streptococcus agalactiae. Large-
colony-forming phenotypes of GCS (Streptococcus
dysgalactiae subsp. equisimilis) and GGS are closely
related and are often termed ‘pyogenes-like’,
because they share virulence factors, including
haemolysins, extracellular enzymes, and M-pro-
teins, with group A streptococci (S. pyogenes)
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[12,14–16]. Small-colony-forming phenotypes,
regardless of Lancefield group carbohydrate, are
placed in the Streptococcus anginosus group (for-
merly known as Streptococcus milleri), and are not
believed to be significant causes of pharyngitis,
but are infrequent causes of abscess formation
and bacteraemia [6,8,17,18].
A limited number of studies in children have
suggested that large-colony-forming species of
GCS and GGS may have a role in acute, sporadic
pharyngitis in children [17]. A cross-sectional
study was therefore performed to further inves-
tigate this possible role.
M A T E R I A L S A N D M E T H O D S
A prospective study of children (6 months to 18 years of age)
who presented with pharyngitis, based on symptoms and
clinical findings, was conducted. Patients from the emergency
department of the Alfred I. duPont Hospital for Children and
two outpatient paediatric offices in Delaware, affiliated with
the hospital, were surveyed for a 1-year period from 1 April
1999. Control patients were children who presented during the
same time period with non-respiratory tract symptoms (e.g.,
lacerations and musculoskeletal injuries) at the same locations,
in addition to the orthopaedic cast clinic at the Alfred I. duPont
Hospital for Children. Children with a history of recent
antibiotic use within 5 days of presentation were excluded.
Subjects were only enrolled in the study once.
Emergency department physicians were instructed to swab
the posterior oropharyngeal wall and the tonsils bilaterally
with a sterile rayon-tipped cotton swab. This technique was
standardised by the use of an illustration of the anatomical
area on the data-collection form provided for each patient at
the time of enrolment. After collection, the transport medium
of the culturette was activated, and the specimen was
transported to the hospital laboratory, where each swab was
plated on two Strep-Selective Agar media plates (Remel Inc.,
Lenexa, KS, USA). Plates were incubated anaerobically at
35 C to optimise recovery of b-haemolytic colonies, and
examined after 24 and 48 h. b-Haemolytic isolates were
subcultured on fresh sheep blood agar plates. Lancefield
grouping was performed with the PathoDx agglutination kit
(Remel Inc.). Streptococcal isolates were identified with the
API 20S Strep Strip (bioMerieux Vitek, Hazelwood, MO, USA).
Informed consent was obtained before enrolment of all
control patients. Consent was not obtained for case patients,
because throat swabs formed part of standard care and the
results of this study would not affect treatment. Approval of
the study was obtained prior to initiation from the Committee
on Human Subjects of the Alfred I. duPont Hospital for
Children.
Rates of isolation of b-haemolytic streptococci were calcu-
lated for both the pharyngitis patients and the controls. The
odds ratio and 95% confidence interval of the association
between pharyngitis and isolation of large-colony-forming
group C and G streptococci were calculated. Data were
analysed using the SAS statistical system (SAS Institute, Cary,
NC, USA) and STATA 6.0 (StataCorp College Station, TX,
USA).
R E S U L T S
Patients with pharyngitis (n ¼ 2085) and 194
controls were enrolled. The median age of
patients was 6.0 years (interquartile range: 3–
9 years), and that of controls was 10.0 years
(interquartile range: 6–13 years). The patients
were younger than the controls (p < 0.001).
Among the patients, there were 991 (48%) males,
while 102 (53%) of the controls were males
(p > 0.5). The controls were more likely to be
enrolled from a hospital site than were the
patients (90% vs. 49%, p < 0.001).
Overall, the isolation rates of all non-group A
b-haemolytic streptococci were 17.7% (370 ⁄ 2085)
from study patients and 9.8% (19 ⁄ 194) from
controls. Table 1 shows that large-colony-forming
GCS and GGS phenotypes were detected at a low
rate (3%) in pharyngitis patients, but this was
twice the rate seen in the controls (Table 1).
However, this difference was not statistically
significant. Group A b-haemolytic streptococci
were isolated from 455 (21.8%) of the study
patients and from 29 (14.9%) of the controls
(p ¼ 0.03).
D I S C U S S I O N
A low prevalence of large-colony-forming GCS
and GGS was demonstrated in a large cohort of
children who presented with acute pharyngitis.
The study was performed over the course of
1 year to reduce the possible effects of seasonal
variation in the prevalence of GCS and GGS, and
patients from different ambulatory settings were
evaluated. The observed odds ratio of 2.0 suggests
that these organisms may be causative of this
disease; however, the 95% confidence interval
crosses unity, and therefore definite conclusions
cannot be drawn. Nevertheless, the rate of isola-
tion of these organisms in this setting is low (3%),
and therefore, even if they cause sporadic
pharyngitis, GCS and GGS would represent an
uncommon cause in the population of children
studied.
The importance of GCS and GGS as causes of
sporadic pharyngitis in children is controversial.
Turner et al. [13] reported that patients from whom
large-colony-forming (S. equisimilis) group C
organisms were isolated had more clinical features
of group A streptococcal infection than did patients
from whom small-colony-forming (S. anginosus)
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organisms were isolated. Cimolai et al. [17]
showed a non-statistically significant association
between large-colony-forming GCS and GGS in
children with pharyngitis when compared to
controls, consistent with the findings of the
present study. The difference became significant
when the comparison was limited to moderate or
heavy growth of these streptococci as determined
by semiquantitative culture methods. This dis-
tinction was not made in the present assessment
of the cultures. Several other studies that did not
distinguish between large-colony-forming and
small-colony-forming species found no increased
association between GCS and GGS and pharyn-
gitis [17,19,20]. These studies may have missed
the association by including both small-colony-
forming (non-pathogenic) and large-colony-form-
ing (pathogenic) GCS and GGS in the analysis.
Even if this association is true, its clinical
significance is unclear, since cases of rheumatic
fever after pharyngitis with GCS and GGS have not
been reported. Interestingly, however, investiga-
tors in Australia recently reported a high carriage
rate of GCS and GGS in an Aboriginal population
that had a high rate of rheumatic fever but a low
incidence of group A streptococcal disease. It was
demonstrated in vitro that GCS and GGS have the
potential to elicit an autoimmune response that
may trigger acute rheumatic fever. This relation-
ship needs to be further explored in Aboriginal
and other populations, since rigorous studies on
preceding GCS and GGS infections in patients
with rheumatic fever have not been performed
[21]. If such an association were found, the clinical
significance of the low rate of large-colony-form-
ing GCS and GGS that was observed in the current
study would need to be re-evaluated.
The prevalence of group A disease in the
patients in the present study was similar to that
reported in previous studies of children with
pharyngitis [3,15,16]. This suggests that the
results may be extrapolated to similar paediatric
patients at other institutions or paediatric prac-
tices.
There are several limitations of the present
study. First, although the survey involved the
largest series of pharyngitis cases cultured for
large-colony-forming GCS and GGS to date, the
wide odds ratio confidence intervals suggest that
this study had limited power to find an associ-
ation. Furthermore, the low rate of colonisation
did not control for potential confounding factors
in the analysis, such as age and location, both of
which were different between cases and controls.
It is plausible that age was a potential confounder,
because there are suggestions in the literature that
the isolation rates of GCS and GGS may be even
higher in older children and adolescents [11].
With respect to location, the outpatient offices
used in the study are hospital-affiliated practices
and serve the same population as the emergency
department, and therefore any differences bet-
ween cases and controls are unlikely to alter the
study findings.
Second, since the disease was already present
at the time of culture, it cannot be determined if
the GCS and GGS presence in the pharynx even
preceded the pharyngitis. However, there is no
reason to believe that subjects with pharyngitis
would be at increased risk of colonisation with
streptococci, and therefore the limitations of the
cross-sectional study design are minimised in this
setting.
Third, patient outcomes were not followed to
determine if controls with large-colony-forming
GCS and GGS developed pharyngitis. Prospective
studies of this sort would provide stronger evi-
dence of association and would provide attack
Table 1. Association between isola-










Large-colony GCS (S. dysgalactiae
subsp. equisimilis) and GGS
65 (3.1%) 3 (1.5%) 2.0 (0.6–6.1)
Group C 33 (1.6%) 1 (0.5%) 3.1 (0.5–126)
Group G 32 (1.5%) 2 (1.0%) 1.5 (0.4–13.0)
Small-colony GCS and GGS 101 (4.8%) 9 (4.6%) 1.0 (0.5–2.1)
Group A b-haemolytic streptococci 455 (21.8%) 29 (14.9%) 1.6 (1.1–2.5)a
ap ¼ 0.03.
GCS, group C streptococci; GGS, group G streptococci.
Zaoutis et al. Group C and group G streptococci in pharyngitis 39
 2004 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 10, 37–40
rates when these organisms are present. However,
the low rate of colonisation and the low point
estimate of the association (i.e., an odds ratio of
2.0) suggest that a very large cohort study design
would be required to confirm an association.
In summary, in this largest series to date, there
was a low rate of isolation of large-colony-form-
ing species of GCS and GGS from paediatric
patients with acute, sporadic pharyngitis.
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